Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Worldwide, rivaroxaban is increasingly used for stroke prevention in atrial fibrillation and treatment of venous thromboembolism, but little is known about rivaroxaban-related bleeding complications in daily care. Using data from a prospective, noninterventional oral anticoagulation registry of dail...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Beyer-Westendorf, Jan, Förster, Kati, Pannach, Sven, Ebertz, Franziska, Gelbricht, Vera, Thieme, Christoph, Michalski, Franziska, Köhler, Christina, Werth, Sebastian, Sahin, Kurtulus, Tittl, Luise, Hänsel, Ulrike, Weiss, Norbert
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2014
Témata:
Thrombosis and Hemostasis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4126334/
https://ncbi.nlm.nih.gov/pubmed/24859362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-03-563577
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky